Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD
· Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Oct 03, 2025, 3:59 PM
1.06
1.86%
After-hours: Oct 03, 2025, 07:58 PM EDT
1.96% (1D)
| Bid | 1.02 |
| Market Cap | 105.97M |
| Revenue (ttm) | 4.36M |
| Net Income (ttm) | -55.26M |
| EPS (ttm) | -0.96 |
| PE Ratio (ttm) | -1.08 |
| Forward PE | -3 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.06 |
| Volume | 2,085,848 |
| Avg. Volume (20D) | 1,122,620 |
| Open | 1.04 |
| Previous Close | 1.02 |
| Day's Range | 1.02 - 1.06 |
| 52-Week Range | 0.75 - 1.80 |
| Beta | 1.19 |
| Ex-Dividend Date | n/a |
About LUCD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LUCD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LUCD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLucid Diagnostics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-19.69%
Lucid Diagnostics shares are trading lower after t...
Unlock content with
Pro Subscription
3 weeks ago
+3.25%
Lucid Diagnostics shares are trading lower after the company announced a proposed public offering.
3 weeks ago · seekingalpha.com
Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)Lucid Diagnostics Inc. (NASDAQ:LUCD ) Investor Conference Call Company Participants Matthew Riley - Director of Investor Relations Lishan Aklog - Chairman & CEO Dennis McGrath - Chief Financial Office...
